FFMMX | MDDLX | FFMMX / MDDLX | |
Total Expense Ratio | 0.36 | 0.94 | 38% |
Annual Report Gross Expense Ratio | 0.36 | 0.94 | 38% |
Fund Existence | 5 years | 21 years | - |
Gain YTD | 9.167 | 6.797 | 135% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 108B | 337M | 32,047% |
Annual Yield % from dividends | 1.76 | 1.62 | 109% |
Returns for 1 year | 11.52 | -15.97 | -72% |
Returns for 3 years | 30.65 | -7.63 | -402% |
Returns for 5 years | N/A | 17.43 | - |
Returns for 10 years | N/A | -17.60 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CGFEX | 78.97 | 0.50 | +0.64% |
American Funds Growth Fund of Amer 529E | |||
JSCVX | 22.18 | N/A | N/A |
Janus Henderson Small Cap Value T | |||
JFNSX | 62.73 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
MSEEX | 25.24 | N/A | N/A |
Morgan Stanley Europe Opportunity C | |||
VILSX | 37.38 | -0.30 | -0.80% |
Value Line Select Growth Institutional |